Gustavo Salgado-Garza

Gustavo Salgado-Garza

Auto-generated profile, based on publicly available information

Gustavo Salgado-Garza

Department of Surgery, Oregon Health & Science University, Portland, USA

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 August 2021 in Journal of Endovascular Therapy
Verified
Journal Article
Closed access
PDF file
DHDavid Hinojosa
David Hinojosa
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
MTMauricio Torres-Martinez
Mauricio Torres-Martinez
SLSergio Uriel Villegas-De Leon
Sergio Uriel Villegas-De Leon
LBLuis Carlos Bueno-Gutierrez
Luis Carlos Bueno-Gutierrez
EFEduardo Flores-Villalba
Eduardo Flores-Villalba
Endovascular treatment through either percutaneous transluminal angioplasty (PTA) alone or stenting has been previously used as a treatment for transplant renal artery stenosis (TRAS). This review aimed to investigate the results of endovascular treatment for renal artery stenosis in transplanted kidneys as compared with the outcomes of interventions, medical management, and graft survival in non-TRAS patients. A systematic review of PubMed, Google Scholar, Cochrane, and Scopus was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines in which studies that reported outcomes of the treatment of TRAS via the endoluminal approach were identified, and their results were meta-analyzed. Fifty-four studies with a total of 1522 patients were included. A significant reduction of serum creatinine level was found, favoring the stenting group, with a mean difference of 0.68 mg/dL (95% confidence interval (CI), 0.17–1.19; Z=2.60, p=0.0009). Comparison of pre- and post-intervention values of any intervention revealed a significant decrease in overall serum creatinine level (0.65 mg/dL; 95% CI, 0.40–0.90; Z=5.09, p=0.00001), overall blood pressure, with a mean difference of 11.12 mmHg (95% CI, 7.29–14.95; Z=5.59, p=0.00001), mean difference in the use of medications (0.77; 95% CI, 0.29–1.24; p=0.002), and peak systolic velocity (190.05; 95% CI, 128.41–251.69; p<0.00001). The comparison of serum creatinine level between endovascular interventions and best medical therapy favored endovascular intervention, with a mean difference of 0.23 mg/dL (95% CI, 0.14–0.32; Z=5.07, p<0.00001). Graft survival was similar between the treated patients and those without TRAS (hazard ratio, 0.98; 95% CI, 0.75–1.28; p=0.091). The overall pooled success rate was 89%, and the overall complication rate was 10.4%, with the most prevalent complication being arterial dissection. The endovascular treatment of TRAS improves graft preservation and renal function and hemodynamic parameters. PTA + stenting appears to be a more effective option to PTA alone in the stabilization of renal function, with additional benefits from decreased restenosis rates. Further high-quality studies could expand on these findings.

1 February 2021 in Annals of Medicine & Surgery
Verified
Journal Article
Open access
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
PHPamela Hernandez-Arriaga
Pamela Hernandez-Arriaga
MGMauricio Gonzalez-Urquijo
Mauricio Gonzalez-Urquijo
JDJosé Antonio Díaz-Elizondo
José Antonio Díaz-Elizondo
EFEduardo Flores-Villalba
Eduardo Flores-Villalba
MRMario Rodarte-Shade
Mario Rodarte-Shade
Mirizzi syndrome is an infrequent complication of long-standing cholelithiasis. Extrinsic compression of the common hepatic duct is usually caused by an impacted stone in Hartmann's pouch or cystic duct resulting in the development of cholecystobiliary fistula. This syndrome is classified based on the presence and severity of cholecystobiliary fistula. Mirizzi syndrome is challenging to diagnose preoperatively and may require complex biliary surgical procedures for resolution. We present three patients with Mirizzi syndrome with different clinical presentations. All were successfully treated by cholangioscopy with electrohydraulic lithotripsy. Endoscopic treatment is a safe alternative with a high success rate. Single-operator cholangioscopy combined with lithotripsy has been shown to have a 90–100% success rate in the treatment of biliary stones. Herein, we present our experience treating Mirizzi syndrome with single-operator cholangioscopy guided electrohydraulic lithotripsy. Difficult management of Mirizzi syndrome has led to research of new treatment options to minimize the risk of high-rate complications. Single-operator cholangioscopy in combination with laser lithotripsy is an adequate and safe alternative for the treatment of this condition.

1 February 2021 in Pharmacological Research
Verified
Journal Article
Closed access
Carlos Enrique Guerrero-BeltránCarlos Enrique Guerrero-Beltrán
Carlos Enrique Guerrero-Beltrán
IMIván Alfredo Mijares-Rojas
Iván Alfredo Mijares-Rojas
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
NGNoé Francisco Garay-Gutiérrez
Noé Francisco Garay-Gutiérrez
BCBelinda Carrion
Belinda Carrion

11 April 2025 in Journal of Robotic Surgery
Verified
Journal Article
Closed access
PDF file
DHDavid Hinojosa
David Hinojosa
GSGal Saffati
Gal Saffati
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
CGCecilio Armengol Garcia
Cecilio Armengol Garcia
MCMadeline Chaput
Madeline Chaput
WMWesley A. Mayer
Wesley A. Mayer

12 June 2024 in Surgery
Verified
Journal Article
Closed access
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
RPRanish K. Patel
Ranish K. Patel
EGErin W. Gilbert
Erin W. Gilbert
BSBrett C. Sheppard
Brett C. Sheppard
PWPatrick J. Worth
Patrick J. Worth

29 June 2022 in Turkish Journal of Surgery
Verified
Journal Article
Open access
PDF file
DHDavid Hinojosa
David Hinojosa
ETEduardo Tellez-Garcia
Eduardo Tellez-Garcia
GSGustavo Salgado-Garza
Gustavo Salgado-Garza
ARAndres Roblesgil-Medrano
Andres Roblesgil-Medrano
LBLuis Carlos Bueno-Gutierrez
Luis Carlos Bueno-Gutierrez
EFEduardo Flores-Villalba
Eduardo Flores-Villalba
Objective: Orthotopic liver transplantation (OLT) remains the definitive treatment for patients afflicted with end-stage liver disease (ESLD). Transjugular intrahepatic portosystemic shunts (TIPS) have been adapted as a bridge to transplantation, allowing partial normalization of portal pressure and associated symptom improvement. Conflicting evidence exists on TIPS’ impact on operative procedures. This study aimed to analyze available evidence on patients who underwent OLT with prior TIPS compared to OLT alone with the intent to determine TIPS’ impact on surgical outcomes. Material and Methods: Following PRISMA guidelines, a systematic review was conducted, identifying studies comparing TIPS + OLT versus OLT alone in patients with ESLD. Data were analyzed using Review Manager 5.3. Results: Thirteen studies were included. Operative time, packed red blood cells transfusions, intensive care unit admission, length of stay, dialysis, serum creatinine levels, ascites, vascular complications, bleeding revisions, reintervention, and other complications rates were similar between both groups. Fresh frozen plasma transfusion -2.88 units (-5.42, -0.35; p= 0.03), was lower in the TIPS + OLT group. Conclusion: Our study found TIPS can be safely employed without having detrimental impacts on OLT outcomes, furthermore, these findings also suggest TIPS does not increase bleeding or complications.